On July 17, 2025, INVO Fertility, Inc. announced that an investor exercised their right to buy 200 shares of Series C-2 Convertible Preferred Stock for $200,000, adjusting the conversion price to approximately $1.9953 per post-split share. Additionally, shareholders approved increasing authorized common shares from 1,388,888 to 50,000,000 during the annual meeting on July 23, 2025.